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Abstract
Background: Numerous studies have been presented on histological grading of oral 
squamous cell carcinomas (OSCC) for predicting survival, but uncertainty of their 
usefulness rises due to discordances of results. A scoring system should be robust 
and well validated, and intra- and interrater agreement can be used as a tool to visual-
ize the strength of reproducibility.
Methods: Here, we present an intra- and inter-observer study on evaluation of OSCC 
using some of the most common histopathological parameters. The observers were 
from different Norwegian university hospitals, and calibration to ensure accuracy 
was first performed. Percentage of the agreement was calculated for the score made 
by the individual observer at different times, as well as between pairs of observers.
Results: The evaluation made by the same observer at two different time points (in-
trarater) correlated better than observations made by different participants (inter-
rater). In an attempt to increase the rate of agreement, many of the parameters were 
either dichotomized into simply low- and high grade, or to a three-tier system when 
more than three options in the original design. This increased the concurrence with 
15.4% for the intrarater and with 23% for the interrater comparisons.
Conclusion: High agreement for histopathological parameters can be difficult to ob-
tain on hematoxylin and eosin staining in scoring systems with many options. A sim-
pler system might be more advantageous to achieve higher degree of reproducibility.
K E Y W O R D S
histopathological parameters, intrarater and interrater agreement, oral cancer, squamous cell 
carcinoma
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1  | INTRODUC TION
Oral cavity cancer originates almost exclusively from squamous cells 
(SC), and the histopathological evaluation of these tumors is the 
basis for their classification and further treatment.
The prediction of outcome and the selection of treatment for pa-
tients with oral squamous cell carcinomas (OSCC) are today based 
on the clinical tumor, nodes, and metastasis (TNM) staging. Tumor 
thickness, as measured during microscopic evaluation, was recently 
implemented in the T (size) variable.1 Further, according to the WHO 
classification of head and neck (HN) tumors, the tumor differentiation 
should also be reported in order to predict prognosis.2 The histolog-
ical grading does not take into account the tumor-host interactions 
that modulate tumor progression and aggressiveness although several 
factors such as inflammation are likely to influence on prognosis.3,4
During the last decades, several histopathological grading sys-
tems for SC carcinomas in the HN region have been suggested and 
tested. The first grading systems only considered the morpholog-
ical characteristics of the tumor, but later on, the tumor-host rela-
tionship also came into consideration.5,6 For evaluation of tumor 
differentiation, nuclear polymorphism and keratinization have 
been important variables.7,8 The characteristics of tumor invasion 
in the surrounding tissue have been implemented when evalu-
ating the tumor-host relationship, as well as immune response 
(plasma-lymphocytic infiltration), vascular invasion, and perineu-
ral infiltration.4,8 In particular, tumor budding (invading clusters of 
four or less tumor cells at the invasive front) has been proposed to 
be a simple and reliable prognostic marker for OSCC.9
Reproducibility in the scoring of histopathological parameters is 
essential if they are to be used as prognostic markers. The purpose 
TA B L E  1   Histopathological parameters evaluating tumor characteristics, invasion patterns, stromal reactions, and peritumoral tissue
Variable
Score
1 2 3 4 5
Differentiation, 
WHO whole tumor7









(>50% of the cells)
Moderately 
keratinized (20%-
50% of the cells)
Minimal 
keratinization (5%-
20% of the cells)







(>50% of the cells)
Moderately 
keratinized (20%-
50% of the cells)
Minimal 
keratinization (5%-
20% of the cells)







































Perineural infiltration None Nerves at invasive 
front









Little or none   






cords, bands, and/or 
strands
Small groups of 
cords of infiltrating 
cells (n > 15 cells)
Marked and widespread 
cellular dissociation in 
small groups and/or in 
single cells (n < 15 cells)
Tumor satellites 
of any size 




(not fibrosis) at 
the tumor-host 
interface
Vascular infiltration Present Not present    
Infiltration Subepithelial tissue 
(submucosa/lamina 
propria)
Muscle Bone   
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of this study was to test the intra- and interrater agreement of a 
broad spectrum of parameters previously suggested as prognostic 
markers for OSCC.
2  | MATERIAL S AND METHODS
2.1 | Observers and calibration
The observers were experienced pathologists/oral pathologist 
(TMS, EN, HL, ACJ, LUH, and SES), and two oral pathologist under 
training (DEC and EHO) from three university hospitals in Norway. 
Prior to the scoring, all the participants had taken part in two calibra-
tion workshops to agree on how to interpret the parameters.
One of the observers performed only one round of scoring, and 
one observer scored thickness and depth only once. The interrater 
observations were all calculated on the first set of scoring allowing 
all eight observers to participate.
2.2 | Slides for evaluation
Hematoxylin and eosin (HE) stained sections of 31 randomly se-
lected formalin-fixed OSCC cases, representing various intraoral 
locations and different tumor stages, were distributed to each 
hospital. The participants reported each case with the assump-
tion that the single slide available was representative of the 
whole lesion. No special stains were provided. The scoring was 
done independently by the observers for each variable at two dif-
ferent time points (3-6 month interval) permitting calculation of 
inter- and intrarater reliability. Thickness and tumor depth were 
measured in millimeter, but for statistical analyses, measure-
ments were divided into three-triers; size ≤5 mm, 5.1-10.0 mm 
and >10 mm. This is according to The International Consortium 
for Outcome Research (ICOR) in Head and neck Cancer and TNM 
Classification of Malignant tumors.10 Tumor budding was divided 
according to recommendations by Almangush et al9; <5 buds as 
low grade, 5-9 as intermediate grade, and ≥10 as high grade. The 
measurement of all other variables was on a nominal scale with 
three to six categories with no overlaps (mutually exclusive) as 
shown in Table 1.
2.3 | Ethics
The study was approved by the Northern Norwegian Regional 
Committee for Medical Research Ethics (REK Nord; 2013/1786 and 
2015/1381).
TA B L E  2   Definition of categories
Tumor characteristics Original variables Categorization 1 Categorization 2 Categorization 3
WHO differentiation, whole tumor WHO 
pattern, worst pattern
Well Low-grade   
Moderate
Poor High-grade












Perineural infiltration None No
Invasive front Yes
Tumor center
Lymphocytic infiltrate Marked Marked Abundant
Moderate Not marked
Little Little
Pattern of invasion Broad pushing Low-grade Low-grade Low-grade
Pushing fingers/large 
islands
Invasive islands >15 cells Intermediate-grade High-grade
Invasive islands <15 cells High-grade High-grade
Tumor satellites
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2.4 | Statistics
Statistics was performed by using IBM SPSS statistics 24. We did 
statistical calculations both in percent agreement and Cohen's 
kappa (ĸ). The variability (spread of scoring) was low, and therefore, 
Cohen's kappa was of no/little value; thus, all correlations are given 
in percent.
3  | RESULTS
3.1 | Intrarater and interrater agreement
The first nine parameters in Table 1 had three to five different scor-
ing options, and they were all categorized into new groups with 
fewer options (Table 2). The first seven were dichotomized, while 
the worst pattern of infiltration had two and three different scoring 
options (Table 2). Lymphocyte infiltration was dichotomized into two 
different groups according to different cut-offs. Dichotomizing vari-
ables increased the mean intrarater agreement from 68.3% (range 
60.7%-77.0%) to 83.5% (range 77.1%-92.5%). Mean agreement for 
each variable prior to and after categorization is listed in Table 3. 
Prior to categorization, perineural infiltration showed the highest 
intrarater agreement, whereas differentiation was most agreed 
upon after categorization.
Some variables had predefined categories that were not changed 
(Table 4). These had a mean intrarater agreement of 85.4% (range 
79.2%-93.3%), and vascular infiltration and infiltration into deeper 
tissues showed the highest intrarater agreement.
In order to evaluate interrater agreement, two observers from dif-
ferent hospitals were paired randomly. The average interrater agree-
ment was lower than the intrarater agreement for all variables (Table 3). 
Dichotomizing variables increased the mean interrater agreement from 
42.9% (range 26.7%-55.9%) to 70.6% (range 59.3%-84.4%). As for the 
intrarater agreement, perineural infiltration and differentiation had 
the highest agreement prior to and after categorization, respectively 
(Table 3). For the variables with predefined categories, the average 
interrater agreement was 72.7% (range 65.0%-78.9%), where vascular 
infiltration was the variable with the highest agreement (Table 4).
4  | DISCUSSION
This study was conducted to investigate how consistent an observer 
was at measuring the same histopathological variables at different 
times, as well as the consistency between different observers. We 
TA B L E  3   Mean percentage of agreement, prior to and after categorization
Tumor 
characteristics
Intrarater, mean agreement, 







Interrater, mean agreement, 
after categorization (%)
Differentiation, WHO whole tumor
77.0 92.5 53.9 84.4
Differentiation, WHO worst pattern




60.7 77.1 46.6 71.4
Degree of keratinization, tumor front
67.3 90.5 54.0 74.6
Nuclear polymorphism, whole tumor
64.3 81.6 36.9 59.7
Nuclear polymorphism, tumor front
64.9 80.2 27.7 59.3
Perineural infiltration
79.9 88.9 55.9 66.4
Lymphocyte infiltration
Category 1 69.2 87.3 50.9 78.6
Category 2 79.9 66.9
Worst pattern of invasion, categorized
Category 1 67.3 71.5 50.1 58.2
Category 2 85.0 78.6
Category 3 83.5 74.7
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found that reducing the number of options for each variable by cat-
egorizing improved the correlation significantly.
Routine histopathological examination of OSCC is important for 
treatment decisions. Grading of differentiation is recommended by 
WHO, but the clinical value is limited. As a result, several other grad-
ing systems have been suggested. An optimal grading system should 
be reproducible, be applicable in all settings, and preferable be per-
formed on standard HE stained sections by pathologist throughout 
the world.
Grading of epithelial dysplasia is poorly reproducible between 
observers, and to improve reproducibility, some advocate a binary 
system with only low- and high grade compared to mild, moderate, 
and severe dysplasia.11 This has been evaluated in several studies 
on trials for oral epithelial dysplasia, but to a lesser extent in OSCC 
where the differentiation still is graded into well, moderate, and 
poor. In general, high-grade tumors (moderately and poorly differ-
entiated) are related to higher degree of recurrence and shorter 
survival time than low-grade tumors.12 Most OSCC are moderately 
or well differentiated, and the classification has not been found to 
correlate well with prognosis.7 In this study, re-categorizing differen-
tiation into low and high improved the reproducibility considerably.
In our study, the mean intrarater agreement was 70% for all 
variables before categorization compared to an interrater agree-
ment of 48%. This indicates that the pairs of observers agreed on 
the tumor grading in less than half of the cases. Lack of reproduc-
ibility questions the reason for using a sophisticated grading sys-
tem, and we, therefore, pooled scores into broader categories. 
This increased the mean of intra- and interrater agreement to 
85% and 71%, respectively, using the best score for lymphocytic 
infiltration (categorization 1) and the best score for worst pattern 
of infiltration (categorization 2). The increase of agreement was 
less pronounced in the intrarater (14.9%) than in the interrater 
group (23.0%).
For the worst pattern of invasion, immunohistochemical staining 
for cytokeratin could ease the recognition of tumor cells among stro-
mal cells, and thus, make scoring more reproducible. The low grade of 
the agreement for this variable in our study indicates that HE stain-
ing only is not sufficient. Likely, parameters such as number of buds, 
tumor thickness, depth of tumor, and infiltration into the underlying 
tissue could also benefit from special staining of epithelial cells. To 
our knowledge, no special staining has been promoted before scor-
ing these variables in the different proposed scoring systems. The 
intrarater agreement for the budding, tumor thickness, and depth 
of infiltration was however 80% and 70% for the interrater groups, 
suggesting that HE stain is sufficient for categorized variables.
Other studies have shown a higher grade of interrater agree-
ment compared to our results. In a study by Rodrigues et al,13 50 
random samples of OSCC were selected and examined for worst 
pattern of invasion twice with a 2-week interval by calibrated ob-
servers. The intra- and interobserver agreement was strong in both 
cases (ĸ = 0.77-0.89 and 0.84). In a study evaluating tumor budding, 
Wang et al14 found excellent intrarater and good interrater agree-
ment (ĸ = 0.880/0.838 and 0.717). The high degree of agreement in 
these two studies might be due to the fact that they only had one 
parameter to score giving this full attention. Also, the time interval 
between first and second scoring in the first study was only 2 weeks 
with the possibility that the observer still could remember the pre-
vious scoring.
5  | CONCLUSION
To be of value, a tumor prognostic marker must be both reproducible 
and significantly associated with disease progression or survival. In 
this study, we have evaluated the reproducibility of a number of pro-
posed histopathological prognostic markers in OSCC. Our findings 
suggest that simpler/uncomplicated scoring protocols will increase 
the reproducibility. However, we have not tested whether the new 
categorizations influence the prognostic value of the parameters. In 
our study, we included most of the previously proposed histopatho-
logical parameters and many observers, but a limited number of pa-
tient samples to avoid fatigue of the observers. We included tumors 
of different stages and from various intraoral locations; thus, the 
cohort was not suited for survival/prognostic analyses. The prog-
nostic value of the revised categorization of the parameters should 
be tested in a larger, more homogenous cohort.
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TA B L E  4   Intra- and interobserver agreement in variables with 












10 mm, >10 mm
80.7 69.6
Depth of invasion, categorized
0-5.0 mm, 5.1-
10 mm, >10 mm
80.7 65.0
Vascular infiltration
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